Re-Focused Kiadis Preps Trials With Natural Killer Cells
Revamped Biotech Trialling NK-cells In AML and HSCT
Kiadis Pharma’s CEO says its processed natural kill cell therapies can improve hematopoietic stem cell transplants and also treat resurgent leukemia.
